Q85.02

Neurofibromatosis, type 2

Billable FY2026 2025-10-01 → 2026-09-30

Exclusions 2 never code together

Q85code

Excludes1

ataxia telangiectasia [Louis-Bar] (G11.3)G11.3
familial dysautonomia [Riley-Day] (G90.1)G90.1

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 1

Q85.02code

Inclusion terms

Acoustic neurofibromatosis

Index entries leading here 1

Neurofibromatosis (multiple) (nonmalignant) Q85.00
- acoustic Q85.02
- type 2 Q85.02

Alongside this code 4 same parent — Q85.0

Q85.00 Neurofibromatosis, unspecified Q85.01 Neurofibromatosis, type 1 Q85.03 Schwannomatosis Q85.09 Other neurofibromatosis

Medications 1

81 Diabetes Mellitus, Type 2 drugs

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references

AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC12 CMS28HCC23 ESRD21HCC12 ESRD24HCC12

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable: yes
Code set: FY2026
Parent: Q85.0
Block: Q80-Q89
Siblings: 4

Present FY2024–FY2027.